IMV Inc IMVIF

RE:RE: DPX-Survivac in Combination with KEYTRUDA® Across

[Hideaway]

Bikkel, could you further define "soon". Do you expect An ORR percentage when Merck releases the preliminary report in a few weeks? I suspect that is what you are referring to because the basket study will not have any reporting for sometime.
If the prelim. results are good, then Merck may take a small stake in IVM but I would be more inclined to see them await further results. Hope you are right as it would really help shareprice.
I agree with others that US promotion is needed. We should expect a US financing in the next few months. We need more awarness in that huge marketplace.
GLTA